Minerals Technologies, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US6031581068
USD
58.63
-0.16 (-0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Minerals Technologies, Inc. stock-summary
stock-summary
Minerals Technologies, Inc.
Specialty Chemicals
Minerals Technologies Inc. is a resource- and technology-based company that develops, produces and markets a range of specialty mineral, mineral-based and synthetic mineral products and related systems and services around the world. It operates through four segments. The Specialty Minerals segment produces and sells the synthetic mineral product precipitated calcium carbonate (PCC), mines mineral ores, and processes and sells natural mineral products, primarily limestone and talc. The Performance Materials segment is a supplier of bentonite and bentonite-related products to industrial and consumer markets globally. The Refractories segment produces and markets monolithic and shaped refractory materials and specialty products, services and application and measurement equipment. The Energy Services segment offers a range of services to improve the production, costs, compliance and environmental impact of activities performed in the oil and gas industry.
Company Coordinates stock-summary
Company Details
622 3rd Ave , NEW YORK NY : 10017-6707
stock-summary
Tel: 1 212 87818001 212 8781840
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 83 Schemes (65.48%)

Foreign Institutions

Held by 110 Foreign Institutions (7.27%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Duane Dunham
Independent Chairman of the Board
Mr. Douglas Dietrich
Chief Executive Officer, Director
Mr. Joseph Breunig
Independent Director
Mr. John Carmola
Independent Director
Dr. Robert Clark
Independent Director
Ms. Alison Deans
Independent Director
Mr. Franklin Feder
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
529 Million
(Quarterly Results - Jun 2025)
Net Profit:
46 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 2,987 Million (Small Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.47%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

14.62%

stock-summary
Price to Book

1.81